StockNews.com initiated coverage on shares of United-Guardian (NASDAQ:UG – Free Report) in a report published on Friday morning. The brokerage issued a buy rating on the stock.
United-Guardian Stock Performance
NASDAQ UG opened at $7.70 on Friday. United-Guardian has a 52-week low of $5.79 and a 52-week high of $10.25. The company has a fifty day moving average of $8.09 and a 200-day moving average of $7.66. The company has a market capitalization of $35.37 million, a P/E ratio of 13.75 and a beta of 0.73.
United-Guardian (NASDAQ:UG – Get Free Report) last issued its quarterly earnings results on Friday, March 22nd. The company reported $0.16 earnings per share (EPS) for the quarter. The firm had revenue of $2.61 million during the quarter. United-Guardian had a return on equity of 24.26% and a net margin of 23.71%.
United-Guardian Announces Dividend
Hedge Funds Weigh In On United-Guardian
A number of large investors have recently added to or reduced their stakes in UG. Vanguard Group Inc. boosted its stake in shares of United-Guardian by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 133,245 shares of the company’s stock valued at $959,000 after purchasing an additional 1,949 shares during the period. Gamco Investors INC. ET AL raised its holdings in United-Guardian by 1.0% during the 4th quarter. Gamco Investors INC. ET AL now owns 156,000 shares of the company’s stock valued at $1,123,000 after buying an additional 1,500 shares during the last quarter. Northern Trust Corp purchased a new stake in United-Guardian during the 4th quarter valued at $151,000. UBS Group AG grew its holdings in United-Guardian by 17.0% in the 3rd quarter. UBS Group AG now owns 33,525 shares of the company’s stock worth $252,000 after acquiring an additional 4,868 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in shares of United-Guardian by 277.1% in the second quarter. Wells Fargo & Company MN now owns 4,521 shares of the company’s stock valued at $37,000 after acquiring an additional 3,322 shares during the period. Hedge funds and other institutional investors own 23.16% of the company’s stock.
United-Guardian Company Profile
United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.
Recommended Stories
- Five stocks we like better than United-Guardian
- What is the Nikkei 225 index?
- The Charles Schwab Company Can Hit New Highs
- The Significance of Brokerage Rankings in Stock Selection
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- 3 Small Caps With Big Return Potential
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.